The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
At Chinaplas 2026, taking place from 21 to 24 April in Shanghai, the ENGEL Group places the reduction of part costs, material ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results